Explore ViiV Healthcare
Collaboration is driving progress with the launch of new Fast-Track City dashboards
ViiV Healthcare is working with the International Association of Providers of AIDS Care on the Fast-Track Cities initiative to harness the power of data to inform and accelerate efforts against the HIV epidemic in cities.
José M. Zuniga, IAPAC President/Chief Executive Officer
Delivering meaningful improvements for people living with and affected by HIV/AIDS around the world comes down to one word: collaboration. On this year’s World AIDS Day, we are fighting HIV together with one of our industry partners - ViiV Healthcare - as part of the Fast-Track Cities initiative. Fast-Track Cities is a global partnership between high HIV burden cities and four core partners – the International Association of Providers of AIDS Care (IAPAC), the Joint United Nations Programme on HIV/AIDS (UNAIDS), the United Nations Human Settlements Programme (UN-Habitat), and the City of Paris. Together, we are working to accelerate AIDS responses in individual Fast-Track Cities to attain the UNAIDS 90-90-90 and zero stigma targets by 2020.
In May 2016, we were proud to announce our IAPAC-ViiV Healthcare collaboration to support 16 cities in urban areas that are particularly affected by HIV, through technical assistance around HIV care continuum and 90-90-90 data generation, analysis, and reporting via web-based platforms. Two months later at AIDS 2016 in Durban, we launched our global Fast-Track Cities web portal and the first series of city dashboards. Today, we are continuing to fight HIV together in cities around the world with the launch of two new web-based dashboards for Melbourne/Victoria, and Miami/Miami-Dade County, as well as presenting updated data on the Denver and San Francisco dashboards that were originally launched at AIDS 2016. These latest dashboards are part of our unrelenting commitment to address the public health challenge of urban HIV and will track each city’s progress towards attaining the 90-90-90 targets for HIV care.
The Fast-Track City dashboards serve as a live tool for the HIV community, including clinicians, the public health community and people living with HIV (PLHIV) to advocate accelerated local HIV responses – holding each other accountable through an embrace of the transparent use of local HIV care continuum and 90-90-90 data. These web-based dashboards will help city-wide stakeholders and the public health community to measure, monitor and provide feedback on progress made towards attaining the initiative’s decisive targets. The dashboards also allow participating cities to see the continuing progress made and learn from strategies deployed in other cities, and to directly connect with each other through a global Fast-Track Cities web portal to promote a sense of solidarity across the Fast-Track Cities network.
Since Fast-Track Cities was originally launched on World AIDS Day 2014 in the City of Paris, cities in every region of the world have signed the Paris Declaration on Fast-Track Cities Ending the AIDS Epidemic, pledging to accelerate their local AIDS responses to attain the 90-90-90 targets, which are defined as 90% of PLHIV knowing their status, 90% of PLHIV who know their status on antiretroviral therapy (ART), and 90% of PLHIV on ART achieving viral suppression. Attaining these targets by 2020 will contribute to achieving the Sustainable Development Goal of ending AIDS as a public health threat by 2030.
Through our work with ViiV Healthcare and our other partners, IAPAC is working to achieve one common goal: to secure for future generations something we once thought was not even remotely possible – a world in which new HIV infections and AIDS-related deaths are exceedingly rare.
 90-90-90 are ambitious HIV testing, care, and treatment targets that mathematical modelling indicate, if attained by 2020, could help to end AIDS as a public health threat by 2030. The targets are defined as 90% of all PLHIV knowing their HIV status, 90% of all people with diagnosed HIV infection receiving sustained antiretroviral therapy (ART), and 90% of all PLHIV receiving ART achieving viral suppression.